Search - tctmd.com

Displaying 201 - 220 of 238

Sort: Relevancy | Date

Presentation TCT 2012

TCT-13. Renal Resistive Indices, Urinary Albumin Excretion and Renal Function in Patients with Resistant Hypertension After Catheter-based Renal Sympathetic Denervation

Presenter: Felix Mahfoud

October 23, 2012

Presentation TCT 2012

TCT-12. Long-term Follow-up of Catheter-based Renal Denervation for Resistant Hypertension Confirms Durable Blood Pressure Reduction

Presenter: Markus Schlaich

October 23, 2012

Presentation TCT 2012

TCT-11. Renal Sympathetic Denervation - Inducing an Instantaneous and Persisting 24h Ambulatory Blood Pressure Drop in Patients With Resistant Hypertension – Results from the...

Presenter: Alexander Plehn

October 23, 2012

Presentation TCT 2012

TCT-356: Circumferential Therapeutic Ultrasound for the Treatment of Resistant Hypertension: Preliminary Results of Human Feasibility Study (SOUND-ITV)

Presenter: Peter Neuzil

October 23, 2012

News Industry News

Vessix Vascular to Present 3-Month, 6-Month Results From REDUCE-HTN Renal Denervation Clinical Study at TCT

October 22, 2012

News Industry News

Two-Year Follow-Up Of Symplicity Htn-1 Data Confirms Significant And Sustained Blood Pressure Reduction In Expanded Cohort Of Patients

October 22, 2012

News Daily News

Almost 1 in 10 STEMIs Caused by Stent Thrombosis

October 12, 2012

News Industry News

Medtronic Completes First-In-Man Study for Investigational Next-Generation Multi-Electrode Renal Denervation System in Patients with Treatment-Resistant Hypertension

October 03, 2012

News Industry News

Medtronic Initiates First Clinical Trial of the Symplicity™ Renal Denervation System for Treatment-Resistant Hypertension in Japan

October 01, 2012

News Daily News

Un Modelo Sugiere que la Denervación Renal es Rentable contra la Hipertensión Resistente

September 13, 2012

News Daily News

Model Suggests Renal Denervation Cost-effective for Resistant Hypertension

September 13, 2012

News Industry News

Health-Economic Analysis Suggests Medtronic Symplicity™ Renal Denervation System Is Cost-Effective and May Reduce Cardiovascular Event Risks for Patients with Treatment-Resistant Hypertension

September 12, 2012

Presentation

Cost-effectiveness and Clinical Effectiveness of Catheter-Based Renal Denervation for Resistant Hypertension

Presenter: B.P. Geisler

September 12, 2012

News Daily News

Renal Stenting Shows Potential for Marked BP Lowering in Uncontrolled Hypertension

L.A. McKeown

September 10, 2012

News Daily News

Renal Denervation Reduces A-fib Recurrences in Small Study

Jason Kahn

September 07, 2012

News Daily News

La Denervación Renal Reduce las Recurrencias de la FA en un Pequeño Estudio

Jason Kahn

September 07, 2012

News Conference News ESC 2012

Renal Denervation Shows Promise for Heart Failure, Ongoing Success Against Hypertension

August 29, 2012

News Daily News

Renal Denervation Part 2: How Far, How Fast for Promising New Therapy?

June 12, 2012

News Daily News

Renal Denervation: Treatment for Hypertension Captures Interventional Spotlight

June 05, 2012

News Industry News

Renal Denervation Technology from St. Jude Medical Demonstrates Significant Reduction in Blood Pressure

May 16, 2012

Advertisement

TCT-13. Renal Resistive Indices, Urinary Albumin Excretion and Renal Function in Patients with Resistant Hypertension After Catheter-based Renal Sympathetic Denervation

TCT-12. Long-term Follow-up of Catheter-based Renal Denervation for Resistant Hypertension Confirms Durable Blood Pressure Reduction

TCT-11. Renal Sympathetic Denervation - Inducing an Instantaneous and Persisting 24h Ambulatory Blood Pressure Drop in Patients With Resistant Hypertension – Results from the...

TCT-356: Circumferential Therapeutic Ultrasound for the Treatment of Resistant Hypertension: Preliminary Results of Human Feasibility Study (SOUND-ITV)

Vessix Vascular to Present 3-Month, 6-Month Results From REDUCE-HTN Renal Denervation Clinical Study at TCT

Two-Year Follow-Up Of Symplicity Htn-1 Data Confirms Significant And Sustained Blood Pressure Reduction In Expanded Cohort Of Patients

Almost 1 in 10 STEMIs Caused by Stent Thrombosis

Medtronic Completes First-In-Man Study for Investigational Next-Generation Multi-Electrode Renal Denervation System in Patients with Treatment-Resistant Hypertension

Medtronic Initiates First Clinical Trial of the Symplicity™ Renal Denervation System for Treatment-Resistant Hypertension in Japan

Un Modelo Sugiere que la Denervación Renal es Rentable contra la Hipertensión Resistente

Model Suggests Renal Denervation Cost-effective for Resistant Hypertension

Health-Economic Analysis Suggests Medtronic Symplicity™ Renal Denervation System Is Cost-Effective and May Reduce Cardiovascular Event Risks for Patients with Treatment-Resistant Hypertension

Cost-effectiveness and Clinical Effectiveness of Catheter-Based Renal Denervation for Resistant Hypertension

Renal Stenting Shows Potential for Marked BP Lowering in Uncontrolled Hypertension

Renal Denervation Reduces A-fib Recurrences in Small Study

La Denervación Renal Reduce las Recurrencias de la FA en un Pequeño Estudio

Renal Denervation Shows Promise for Heart Failure, Ongoing Success Against Hypertension

Renal Denervation Part 2: How Far, How Fast for Promising New Therapy?

Renal Denervation: Treatment for Hypertension Captures Interventional Spotlight

Renal Denervation Technology from St. Jude Medical Demonstrates Significant Reduction in Blood Pressure

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content